Heterocyclic compounds and uses thereof
HK40134662APending Publication Date: 2026-07-10PROGENTOS THERAPEUTICS INC
Patent Information
- Authority / Receiving Office
- HK · HK
- Patent Type
- Applications
- Current Assignee / Owner
- PROGENTOS THERAPEUTICS INC
- Filing Date
- 2026-04-09
- Publication Date
- 2026-07-10
Abstract
The present disclosure provides compounds that can specifically target a PDGFRα, and thereby, reduce and / or inhibit the activation of the receptor ("PDGFRα inhibitor"). The present disclosure also provides methods of treating a demyelinating disease using the disclosed PDGFRα inhibitors.
Need to check novelty before this filing date? Find Prior Art